BIOMARKER:

EGFR exon 19 deletion + EGFR T790M + EGFR C797S + CTNNB1 exon 3 mutation

Entrez ID:

Related biomarkers:

‹

›

EGFR exon 19 deletion + EGFR T790M + EGFR C797S + CTNNB1 exon 3 mutation EGFR exon 19 deletion + EGFR T790M + EGFR C797S + CTNNB1 exon 3 mutation	Lung Adenocarcinoma LUAD	EGFR exon 19 deletion + EGFR T790M + EGFR C797S + CTNNB1 exon 3 mutation EGFR exon 19 deletion + EGFR T790M + EGFR C797S + CTNNB1 exon 3 mutation	Lung Adenocarcinoma LUAD	osimertinib + gefitinib Resistant: C4 – Case Studies	osimertinib + gefitinib Resistant: C4 – Case Studies
EGFR exon 19 deletion + EGFR T790M + EGFR C797S + CTNNB1 exon 3 mutation EGFR exon 19 deletion + EGFR T790M + EGFR C797S + CTNNB1 exon 3 mutation	Lung Adenocarcinoma LUAD	EGFR exon 19 deletion + EGFR T790M + EGFR C797S + CTNNB1 exon 3 mutation EGFR exon 19 deletion + EGFR T790M + EGFR C797S + CTNNB1 exon 3 mutation	Lung Adenocarcinoma LUAD	icotinib Resistant: C4 – Case Studies	icotinib Resistant: C4 – Case Studies
EGFR exon 19 deletion + EGFR T790M + EGFR C797S + CTNNB1 exon 3 mutation EGFR exon 19 deletion + EGFR T790M + EGFR C797S + CTNNB1 exon 3 mutation	Lung Adenocarcinoma LUAD	EGFR exon 19 deletion + EGFR T790M + EGFR C797S + CTNNB1 exon 3 mutation EGFR exon 19 deletion + EGFR T790M + EGFR C797S + CTNNB1 exon 3 mutation	Lung Adenocarcinoma LUAD	bevacizumab + osimertinib Resistant: C4 – Case Studies	bevacizumab + osimertinib Resistant: C4 – Case Studies
EGFR exon 19 deletion + EGFR T790M + EGFR C797S + CTNNB1 exon 3 mutation EGFR exon 19 deletion + EGFR T790M + EGFR C797S + CTNNB1 exon 3 mutation	Lung Adenocarcinoma LUAD	EGFR exon 19 deletion + EGFR T790M + EGFR C797S + CTNNB1 exon 3 mutation EGFR exon 19 deletion + EGFR T790M + EGFR C797S + CTNNB1 exon 3 mutation	Lung Adenocarcinoma LUAD	bevacizumab + icotinib Resistant: C4 – Case Studies	bevacizumab + icotinib Resistant: C4 – Case Studies